Page last updated: 2024-08-17

quinoxalines and Arterial Diseases, Cerebral

quinoxalines has been researched along with Arterial Diseases, Cerebral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Håberg, A; Haraldseth, O; Hjelstuen, M; Takahashi, M; Yamaguchi, T	1

Other Studies

1 other study(ies) available for quinoxalines and Arterial Diseases, Cerebral

Article	Year
Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion. Brain research, 1998, Nov-16, Volume: 811, Issue:1-2 Topics: Animals; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Drug Evaluation, Preclinical; Imidazoles; Linear Models; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA	1998

Article

Year

Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion.

Brain research, 1998, Nov-16, Volume: 811, Issue:1-2

Topics: Animals; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Drug Evaluation, Preclinical; Imidazoles; Linear Models; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA

1998